Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Soleno Therapeutics Inc (SLNO)
NASDAQ:SLNO
Holding SLNO?
Track your performance easily
See the Price Targets and Ratings of:
SLNO Analyst Ratings
Strong Buy
7 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
SLNO Stock 12 Month Forecast
Average Price Target
$73.71
▲(34.21% Upside)
| Highest Price Target$93.00 | Average Price Target$73.71 | Lowest Price Target$65.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Piper Sandler
Reiterated
10/25/24
Stifel Nicolaus
Assigned
10/09/24
Oppenheimer
Reiterated
10/08/24
Robert W. Baird
Assigned
10/08/24
Laidlaw
Reiterated
10/08/24
H.C. Wainwright
Initiated
09/03/24
Cantor Fitzgerald
Reiterated
08/07/24
Guggenheim
―
Buy
―
Reiterated
12/06/23
We hosted investor meetings with CEO, Dr. Bhatnagar, to address key questions, including (1) historical and near-term regulatory interactions; (2) regulatory precedence / competitive landscape; and (3) DCCR commercial opportunity. Notably, there has been continuity of representation and favorable sentiment evolution from the FDA throughout DCCR’s clinical journey, namely: (1) Dr. Psychiatry, has been participating/leading the discussion with SLNO; (2) OLE NH comparison resulted in the agency shifting from “run another study [C601]” to “generate more data”; and (3) the agency’s position that the RWS if successful, could address their concerns on efficacy. Mgmt is expected to have a pre NDA meeting with the agency over the coming weeks and is likely to update the Street after receiving the meeting minutes. We expect NDA submission by mid 24.
Best Analysts Covering Soleno Therapeutics
Which Analyst Should I Follow If I Want to Buy SLNO and Sell After:
1 Month
xxx
Success Rate
12/23 ratings generated profit
Average Return
+24.70%
reiterated a xxx
rating 28 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 52.17% of your transactions generating a profit, with an average return of +24.70% per trade.
3 Months
xxx
Success Rate
15/23 ratings generated profit
Average Return
+35.05%
reiterated a xxx
rating 28 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 65.22% of your transactions generating a profit, with an average return of +35.05% per trade.
1 Year
Success Rate
12/23 ratings generated profit
Average Return
+156.94%
reiterated a buy rating 28 days ago
Copying Leland Gershell's trades and holding each position for 1 Year would result in 52.17% of your transactions generating a profit, with an average return of +156.94% per trade.
2 Years
xxx
Success Rate
12/23 ratings generated profit
Average Return
+175.80%
reiterated a xxx
rating 28 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 52.17% of your transactions generating a profit, with an average return of +175.80% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
SLNO Analyst Recommendation Trends
Rating
Jun 24
Jul 24
Aug 24
Sep 24
Oct 24
Strong Buy
9
5
6
6
7
Buy
5
4
4
5
9
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
14
9
10
11
16
Each month's total comprises the sum of three months' worth of ratings.
SLNO Financial Forecast
SLNO Stock Forecast FAQ
What is SLNO’s average 12-month price target, according to analysts?
Based on analyst ratings, Soleno Therapeutics Inc’s 12-month average price target is $73.71.
What is SLNO’s upside potential, based on the analysts’ average price target?
Soleno Therapeutics Inc has 34.21% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is SLNO a Buy, Sell or Hold?
Soleno Therapeutics Inc has a consensus rating of Strong Buy which is based on 7 buy ratings, 0 hold ratings and 0 sell ratings.
What is Soleno Therapeutics Inc’s price target?
The average price target for Soleno Therapeutics Inc is $73.71. This is based on 7 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $93.00 ,the lowest forecast is $65.00. The average price target represents 34.21% Increase from the current price of $54.92.
The highest analyst price target is $93.00 ,the lowest forecast is $65.00. The average price target represents 34.21% Increase from the current price of $54.92.
What do analysts say about Soleno Therapeutics Inc?
Soleno Therapeutics Inc’s analyst rating consensus is a Strong Buy. This is based on the ratings of 7 Wall Streets Analysts.
How can I buy shares of SLNO?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.